News + Filings Holdings
|
|
SILVERARC CAPITAL MANAGEMENT, LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
| Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
|
ImmunoGen, Inc.
| IMGN | COM | 1,420,000 | 1,270,000 | 26,795,400,000 | 26,219,400,000 | 8.29 | 0.63 |
Hist
| 06/30/2023 |
|
Morphic Holding, Inc.
| MORF | Common | 252,309 | 200,625 | 14,464,875,000 | 12,519,489,000 | 4.47 | 0.64 |
Hist
| 06/30/2023 |
|
Krystal Biotech, Inc.
| KRYS | Common | 118,941 | 84,927 | 13,963,673,000 | 11,240,512,000 | 4.32 | 0.46 |
Hist
| 06/30/2023 |
|
Schrodinger, Inc.
| SDGR | Common | 286,169 | 73,344 | 14,285,556,000 | 8,681,874,000 | 4.42 | 0.40 |
Hist
| 06/30/2023 |
|
MoonLake Immunotherapeutics
| MLTX | Common | 200,000 | 94,250 | 10,200,000,000 | 7,938,007,000 | 3.16 | 0.38 |
Hist
| 06/30/2023 |
|
Intra-Cellular Therapies, Inc.
| ITCI | Common | 198,723 | 73,688 | 12,583,140,000 | 5,812,495,000 | 3.89 | |
Hist
| 06/30/2023 |
|
BIOGEN INC.
| BIIB | Common | 26,854 | 15,543 | 7,649,362,000 | 4,504,565,000 | 2.37 | |
Hist
| 06/30/2023 |
|
TELA Bio, Inc.
| TELA | Common | 416,440 | 362,344 | 4,218,537,000 | 3,642,956,000 | 1.30 | 1.70 |
Hist
| 06/30/2023 |
|
Akero Therapeutics, Inc.
| AKRO | Common | 241,357 | 38,796 | 11,268,958,000 | 3,518,974,000 | 3.49 | 0.48 |
Hist
| 06/30/2023 |
|
Oric Pharmaceuticals, Inc.
| ORIC | Common | 1,450,822 | 14,877 | 11,258,379,000 | 3,073,492,000 | 3.48 | 3.22 |
Hist
| 06/30/2023 |
|
UNITED THERAPEUTICS Corp
| UTHR | Common | 30,029 | 11,451 | 6,628,902,000 | 2,468,173,000 | 2.05 | 0.06 |
Hist
| 06/30/2023 |
|
Sarepta Therapeutics, Inc.
| SRPT | Common | 29,860 | 20,590 | 3,419,567,000 | 2,141,883,000 | 1.06 | 0.03 |
Hist
| 06/30/2023 |
|
VERACYTE, INC.
| VCYT | Common | 229,451 | 19,798 | 5,844,117,000 | 1,168,855,000 | 1.81 | 0.32 |
Hist
| 06/30/2023 |
|
Cogent Biosciences, Inc.
| COGT | Common | 620,000 | 40,736 | 7,340,800,000 | 1,090,541,000 | 2.27 | 0.87 |
Hist
| 06/30/2023 |
|
Mersana Therapeutics, Inc.
| MRSN | Common | 1,000,000 | 459,941 | 3,290,000,000 | 1,070,358,000 | 1.02 | 0.87 |
Hist
| 06/30/2023 |
|
Intellia Therapeutics, Inc.
| NTLA | Common | 50,858 | 13,000 | 2,073,989,000 | 663,021,000 | 0.64 | 0.06 |
Hist
| 06/30/2023 |
|
INSMED Inc
| INSM | Common | 144,464 | 670 | 3,048,190,000 | 596,502,000 | 0.94 | 0.11 |
Hist
| 06/30/2023 |
|
BIOCRYST PHARMACEUTICALS INC
| BCRX | Common | 760,904 | 183,147 | 5,356,764,000 | 538,271,000 | 1.66 | 0.40 |
Hist
| 06/30/2023 |
|
Xenon Pharmaceuticals Inc.
| XENE | COM | 99,756 | 3,113 | 3,840,606,000 | 381,753,000 | 1.19 | 0.16 |
Hist
| 06/30/2023 |
|
Cue Biopharma, Inc.
| CUE | Common | 403,402 | 97,124 | 1,472,417,000 | 379,005,000 | 0.46 | 0.93 |
Hist
| 06/30/2023 |
|
Mirum Pharmaceuticals, Inc.
| MIRM | Common | 106,375 | 436 | 2,751,921,000 | 207,266,000 | 0.85 | 0.28 |
Hist
| 06/30/2023 |
|
BridgeBio Pharma, Inc.
| BBIO | Common | 50,000 | 10,000 | 860,000,000 | 196,800,000 | 0.27 | 0.03 |
Hist
| 06/30/2023 |
|
Viridian Therapeutics, Inc.\DE
| VRDN | COM | 45,000 | 8,619 | 1,070,550,000 | 145,017,000 | 0.33 | 0.10 |
Hist
| 06/30/2023 |
|
Eliem Therapeutics, Inc.
| ELYM | Common | 494,089 | 8,134 | 1,383,449,000 | -25,821,000 | 0.43 | 1.83 |
Hist
| 06/30/2023 |
|
INCYTE CORP
| INCY | Common | 34,110 | 172 | 2,123,348,000 | -329,351,000 | 0.66 | 0.02 |
Hist
| 06/30/2023 |
|
GILEAD SCIENCES, INC.
| GILD | Common | 60,448 | 318 | 4,658,727,000 | -330,259,000 | 1.44 | 0.00 |
Hist
| 06/30/2023 |
|
CERUS CORP
| CERS | Common Stock | 1,158,265 | 5,363 | 2,849,332,000 | -574,787,000 | 0.88 | 0.65 |
Hist
| 06/30/2023 |
|
PLIANT THERAPEUTICS, INC.
| PLRX | Common | 107,267 | 7,267 | 1,943,678,000 | -716,322,000 | 0.60 | 0.18 |
Hist
| 06/30/2023 |
|
Poseida Therapeutics, Inc.
| PSTX | Common | 2,945,948 | 256,647 | 5,184,868,000 | -3,098,179,000 | 1.60 | 3.39 |
Hist
| 06/30/2023 |
|
|
|
|